Derrick West: Yes. The guidance that’s being given is not for the whole fiscal year. It is that we will achieve that income during the fiscal year in one of our quarters. So starting with the operating cash flow, we finished the year with fairly large increased sales. We do expect sales to continue to grow. We have significantly increased the production level in Moncton. And if we plan in those rooms, that will increase our investment in our biological assets and our inventories. So, as we continue to have success in the marketplace with our products and getting to a higher level of scale, there will be negative cash pressures on the operating activities for the first half of the year. However, we do expect that once we are fully operating our capacity at all facilities that, that will level off and we are confident that we will have a positive operating cash flow prior to the end of fiscal 2023.
And with regards to free cash flow, our main CapEx spend program, while significant in fiscal ’22, we are doing further enhancements in automation in Winnipeg and Moncton and as well with completing the expansion at Laurentian. We expect to have that completed in fiscal 2023. And from there, we have no identified large capital projects. It would be more sustaining capital and as a consequence, as we get into the first part of fiscal ’24, we would expect that positive operating cash flow with nominal CapEx will lead us to a positive free cash flow and that’s why we indicated in the guidance by the end of calendar ’23, which covers our first quarter of next year, of fiscal ’24.
Operator: Your next question comes from the line of Matt Bottomley from Canaccord Genuity. Your line is open.
Matt Bottomley: Good morning everyone. Congrats on a strong finish to the fiscal year. Just wanted to kind of maybe more of a state of the union on what we are seeing and what’s a saturated landscape in just terms of the number of participants in this sector, particularly on the cultivation production? So appreciate all the commentary on how you are positioned and you are pretty much sort of top three in everywhere where you are playing. But are you seeing any shakeouts right now, a lot of the commentary we have had from LPs as of late as there is a bit of what may be a bottoming in market share declines that we have seen pretty much across the board and you guys have been making good progress? So are you seeing that as well or maybe there is less competition for wholesales with the provincial boards? Or is this just more specifically where you are choosing to allocate time and effort in terms of the SKUs that you’re looking at that’s resulting in these gains?
Beena Goldenberg: Well, an interesting question. So let me start by saying, we do see over the course of this past year that, there has been, those cultivation facilities that couldn’t compete whether it was on quality or price that have shuttered, that has taken some capacity out of the marketplace. But there are other players that are still in there, trying to make a goal of it. And so, we are still going to see some level of price competitiveness in the marketplace. We are comfortable because of our cost base that we could compete in the value segment. As I said earlier, we have products that compete in other segments, but the value segment, especially today in the high inflation market is the space, where we expect to see the most growth and we are comfortable participating in that.
